# OnCo record idea-rejuv-core-outcome-set-for-late-effects (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-rejuv-core-outcome-set-for-late-effects/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-rejuv-core-outcome-set-for-late-effects" ;
  schema:name "Agree what to measure, so the next systematic review can pool rather than narrate"@en ;
  schema:description "A reported prevalence of 0 to 84 per cent for the same late effect is a measurement failure. Core outcome sets are cheap, need no new biology, and would unlock the studies the field has already paid for."@en ;
  schema:url <https://onco.cc/ideas/idea-rejuv-core-outcome-set-for-late-effects/> ;
  schema:dateModified "2026-10-02"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jama.2013.6296> ;
  onco:tag "rejuvenation", "survivorship", "open-problem", "outcomes", "methods" ;
  onco:related <https://onco.cc/technologies/rejuv-paed-kidneys/>, <https://onco.cc/technologies/rejuv-ayac-diagnostic-delay/>, <https://onco.cc/technologies/rejuv-mind-fear-of-recurrence/>, <https://onco.cc/technologies/cognitive-impairment-after-cancer-treatment/>, <https://onco.cc/ideas/idea-moon-pro-ctcae-in-every-pivotal-trial/>, <https://onco.cc/collections/ighg/>, <https://onco.cc/roadmaps/rejuvenation-roadmap/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/>, <https://onco.cc/fronts/supportive-care/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/rejuv-agenda-no-agreed-outcome-measures/>, <https://onco.cc/bottlenecks/rejuv-agenda-nothing-restores-cognition/>, <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-reproducibility/> .
